Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia.
| Image |  |
|---|---|
| Description | scientific article published on 24 May 2019 |
| Author/s |
author: Yasuhito Tanaka Kazuhiko Koike |
| Publication date | May 24, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |